<DOC>
	<DOCNO>NCT00076973</DOCNO>
	<brief_summary>The purpose study look whether investigational drug treat breathe symptom RSV bronchiolitis child 3 24 month age .</brief_summary>
	<brief_title>An Investigational Drug Study Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus ( RSV ) Bronchiolitis ( 0476-272 )</brief_title>
	<detailed_description />
	<mesh_term>Bronchiolitis</mesh_term>
	<mesh_term>Signs Symptoms , Respiratory</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Hospitalized urgent/emergentcare set least 24 hour first second episode RSVinduced bronchiolitis . Approximately twenty percent patient allow study stay le 24 hour need meet minimum predefined Respiratory Severity Score require study . Asthma wheeze disorder . The Primary Investigator evaluate whether reason child may participate .</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>RSV Bronchiolitis</keyword>
</DOC>